treatment

Maximilian Stahl, MD

Institution
Yale University School of Medicine
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)

Advances in the Treatment Paradigm of Myeloid Malignancies: From Biology to Clinical Practice

Thumbnail for video Watch Now

Topic(s)
Myelodysplastic Syndromes (MDS)
Presenter(s)
Uma Borate, MBBS
Sudipto Mukherjee, MD, MPH
Abhay Singh, MD, MPH
This complimentary CME satellite symposium provided an in-depth and up-to-date review of research related to the biology, prognosis, natural history, and therapeutic management of patients with AA, PNH, MDS, AML, MPN, and related myeloid malignancies. The overall goal of the…

Iptacopan

FABHALTA, a complement factor B inhibitor, is the first oral medication approved to treat adults with

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.